Correlation Between Bristol Myers and Belite Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Belite Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Belite Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Belite Bio ADR, you can compare the effects of market volatilities on Bristol Myers and Belite Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Belite Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Belite Bio.

Diversification Opportunities for Bristol Myers and Belite Bio

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Bristol and Belite is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Belite Bio ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Belite Bio ADR and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Belite Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Belite Bio ADR has no effect on the direction of Bristol Myers i.e., Bristol Myers and Belite Bio go up and down completely randomly.

Pair Corralation between Bristol Myers and Belite Bio

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.64 times more return on investment than Belite Bio. However, Bristol Myers Squibb is 1.55 times less risky than Belite Bio. It trades about 0.15 of its potential returns per unit of risk. Belite Bio ADR is currently generating about 0.08 per unit of risk. If you would invest  4,069  in Bristol Myers Squibb on September 1, 2024 and sell it today you would earn a total of  1,853  from holding Bristol Myers Squibb or generate 45.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Belite Bio ADR

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
Belite Bio ADR 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Belite Bio ADR are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Belite Bio exhibited solid returns over the last few months and may actually be approaching a breakup point.

Bristol Myers and Belite Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Belite Bio

The main advantage of trading using opposite Bristol Myers and Belite Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Belite Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Belite Bio will offset losses from the drop in Belite Bio's long position.
The idea behind Bristol Myers Squibb and Belite Bio ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios